Greencare Capital - Notice of AGM

Greencare Capital plc

("Greencare" or "the Company")

Notice of AGM

Greencare, (AQUIS: GRE), the investment company focused on investing in medicinal cannabis, CBD and related areas, announces that an Annual General Meeting ("AGM") will be held at 10.00 a.m. on 29 June 2021 at Scott House Suite 1 The Concourse Waterloo Station, London, SE1 7LY.

The Notice of AGM (the "Notice") and Form of Proxy will shortly be available on the Company's website, www.greencare.capital, and will be posted to registered shareholders shortly.

Please note that as at the date of announcement, it is expected that Covid-19 restrictions on indoor meetings will be lifted on 21 June 2021, so prior to the date of the AGM.  However, the possibility remains that such restrictions will be extended beyond 21 June 2021 and so may be in place as at 30 June 2021 and therefore shareholders would be unable to attend the meeting.  In such event, the Company will make an announcement and will make arrangements to ensure the minimum quorum is present.  Shareholders are therefore encouraged to vote in advance by proxy and to appoint the chairman of the Annual General Meeting as their proxy.

Enquiries:

Notes:

Greencare Capital plc is an investment company quoted on the Aquis Stock Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October 2019 and its shares were admitted to trading on 30 December 2019.

The Company's investment strategy is to focus on investments in cannabis sectors within countries predominantly in Europe whose jurisdictions have well-developed and reputable laws and regulations for its production, research and distribution; together with the CBD and hemp sectors.

The Company will invest directly or indirectly in public or private companies, in supply and distribution chains, or other business associated with the cannabis sector. Investments may take the form of debt or equity and it is expected that such investments will ordinarily seek capital growth in the medium term in preference to income.

The Company will not invest in the recreational cannabis sector, or in entities or activities supported by it, nor any other related activities which would be deemed illegal under UK legislation.